Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002
| dc.contributor.author | Karlowsky, James A. | |
| dc.contributor.author | Jones, Mark E. | |
| dc.contributor.author | Draghi, Deborah C. | |
| dc.contributor.author | Thornsberry, Clyde | |
| dc.contributor.author | Sahm, Daniel F. | |
| dc.contributor.author | Volturo, Gregory A. | |
| dc.date | 2022-08-11T08:09:40.000 | |
| dc.date.accessioned | 2022-08-23T16:39:24Z | |
| dc.date.available | 2022-08-23T16:39:24Z | |
| dc.date.issued | 2004-05-10 | |
| dc.date.submitted | 2012-03-22 | |
| dc.identifier.citation | Ann Clin Microbiol Antimicrob. 2004 May 10;3:7. <a href="http://dx.doi.org/10.1186/1476-0711-3-7" target="_blank">Link to article on publisher's site</a> | |
| dc.identifier.issn | 1476-0711 (Linking) | |
| dc.identifier.doi | 10.1186/1476-0711-3-7 | |
| dc.identifier.pmid | 15134581 | |
| dc.identifier.pmid | 15134581 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.14038/39466 | |
| dc.description.abstract | BACKGROUND: Bloodstream infections are associated with significant patient morbidity and mortality. Antimicrobial susceptibility patterns should guide the choice of empiric antimicrobial regimens for patients with bacteremia. METHODS: From January to December of 2002, 82,569 bacterial blood culture isolates were reported to The Surveillance Network (TSN) Database-USA by 268 laboratories. Susceptibility to relevant antibiotic compounds was analyzed using National Committee for Clinical Laboratory Standards guidelines. RESULTS: Coagulase-negative staphylococci (42.0%), Staphylococcus aureus (16.5%), Enterococcus faecalis (8.3%), Escherichia coli (7.2%), Klebsiella pneumoniae (3.6%), and Enterococcus faecium (3.5%) were the most frequently isolated bacteria from blood cultures, collectively accounting for >80% of isolates. In vitro susceptibility to expanded-spectrum beta-lactams such as ceftriaxone were high for oxacillin-susceptible coagulase-negative staphylococci (98.7%), oxacillin-susceptible S. aureus (99.8%), E. coli (97.3%), K. pneumoniae (93.3%), and Streptococcus pneumoniae (97.2%). Susceptibilities to fluoroquinolones were variable for K. pneumoniae (90.3-91.4%), E. coli (86.0-86.7%), oxacillin-susceptible S. aureus (84.0-89.4%), oxacillin-susceptible coagulase-negative staphylococci (72.7-82.7%), E. faecalis (52.1%), and E. faecium (11.3%). Combinations of antimicrobials are often prescribed as empiric therapy for bacteremia. Susceptibilities of all blood culture isolates to one or both agents in combinations of ceftriaxone, ceftazdime, cefepime, piperacillin-tazobactam or ciprofloxacin plus gentamicin were consistent (range, 74.8-76.3%) but lower than similar beta-lactam or ciprofloxacin combinations with vancomycin (range, 93.5-96.6%). CONCLUSION: Ongoing surveillance for antimicrobial susceptibility remains essential, and will enhance efforts to identify resistance and attempt to limit its spread. | |
| dc.language.iso | en_US | |
| dc.relation | <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=15134581&dopt=Abstract">Link to Article in PubMed</a> | |
| dc.relation.url | http://dx.doi.org/10.1186/1476-0711-3-7 | |
| dc.rights | © 2004 Karlowsky et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL. | |
| dc.subject | Bacterial Infections | |
| dc.subject | Bacteremia | |
| dc.subject | Anti-Infective Agents | |
| dc.subject | Bacterial Infections and Mycoses | |
| dc.subject | Emergency Medicine | |
| dc.subject | Life Sciences | |
| dc.subject | Medical Microbiology | |
| dc.subject | Medicine and Health Sciences | |
| dc.title | Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002 | |
| dc.type | Journal Article | |
| dc.source.journaltitle | Annals of clinical microbiology and antimicrobials | |
| dc.source.volume | 3 | |
| dc.identifier.legacyfulltext | https://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=3261&context=oapubs&unstamped=1 | |
| dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/oapubs/2262 | |
| dc.identifier.contextkey | 2691099 | |
| refterms.dateFOA | 2022-08-23T16:39:25Z | |
| html.description.abstract | <p>BACKGROUND: Bloodstream infections are associated with significant patient morbidity and mortality. Antimicrobial susceptibility patterns should guide the choice of empiric antimicrobial regimens for patients with bacteremia.</p> <p>METHODS: From January to December of 2002, 82,569 bacterial blood culture isolates were reported to The Surveillance Network (TSN) Database-USA by 268 laboratories. Susceptibility to relevant antibiotic compounds was analyzed using National Committee for Clinical Laboratory Standards guidelines.</p> <p>RESULTS: Coagulase-negative staphylococci (42.0%), Staphylococcus aureus (16.5%), Enterococcus faecalis (8.3%), Escherichia coli (7.2%), Klebsiella pneumoniae (3.6%), and Enterococcus faecium (3.5%) were the most frequently isolated bacteria from blood cultures, collectively accounting for >80% of isolates. In vitro susceptibility to expanded-spectrum beta-lactams such as ceftriaxone were high for oxacillin-susceptible coagulase-negative staphylococci (98.7%), oxacillin-susceptible S. aureus (99.8%), E. coli (97.3%), K. pneumoniae (93.3%), and Streptococcus pneumoniae (97.2%). Susceptibilities to fluoroquinolones were variable for K. pneumoniae (90.3-91.4%), E. coli (86.0-86.7%), oxacillin-susceptible S. aureus (84.0-89.4%), oxacillin-susceptible coagulase-negative staphylococci (72.7-82.7%), E. faecalis (52.1%), and E. faecium (11.3%). Combinations of antimicrobials are often prescribed as empiric therapy for bacteremia. Susceptibilities of all blood culture isolates to one or both agents in combinations of ceftriaxone, ceftazdime, cefepime, piperacillin-tazobactam or ciprofloxacin plus gentamicin were consistent (range, 74.8-76.3%) but lower than similar beta-lactam or ciprofloxacin combinations with vancomycin (range, 93.5-96.6%).</p> <p>CONCLUSION: Ongoing surveillance for antimicrobial susceptibility remains essential, and will enhance efforts to identify resistance and attempt to limit its spread.</p> | |
| dc.identifier.submissionpath | oapubs/2262 | |
| dc.contributor.department | Department of Emergency Medicine | |
| dc.source.pages | 7 |
